S15 Ep43: Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP Inhibition in Triple-Negative Breast Cancer
OncLive® On Air
00:00
Overview: metastatic TNBC burden and approvals
Heather McArthur outlines prognosis, need for innovation, and recent regulatory approvals in metastatic triple-negative breast cancer.
Play episode from 00:40
Transcript
